Simona Volpi

Researcher Next ID · RN-022473

Researcher · Biochemistry, Genetics and Molecular Biology

National Institutes of Health

Bethesda, Mexico

Not currently recruitingFunding unknown

Works count: 60
Citation count: 32,978
H-index: 34
i10-index: 48

Research interests

Biochemistry, Genetics and Molecular Biology

Psychology

Pharmacology, Toxicology and Pharmaceutics

Genetic Associations and Epidemiology

Neuroendocrine regulation and behavior

Genomics and Rare Diseases

Pharmacogenetics and Drug Metabolism

Bioinformatics and Genomic Networks

Publications

Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects
Clinical Pharmacology & Therapeutics · 2018 · 10.1002/cpt.1048
Genetic effects on gene expression across human tissues
Nature · 2017 · https://doi.org/10.1038/nature24277
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
Clinical Pharmacology & Therapeutics · 2016 · 10.1002/cpt.350
Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems
Clinical Pharmacology & Therapeutics · 2014 · 10.1038/clpt.2014.137
Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia
Schizophrenia Research · 2009 · 10.1016/j.schres.2008.11.025
Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia
The Journal of Clinical Psychiatry · 2009 · 10.4088/jcp.08m04391
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia
Molecular Psychiatry · 2008 · 10.1038/mp.2008.52
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study
Molecular Psychiatry · 2008 · 10.1038/mp.2008.56
Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress
Brain Research · 2007 · 10.1016/j.brainres.2007.01.037
Vasopressinergic Regulation of the Hypothalamic Pituitary Adrenal Axis and Stress Adaptation
Stress · 2004 · 10.1080/10253890410001733535
HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection
The Journal of Immunology · 2002 · 10.4049/jimmunol.169.11.6361

Current projects

No projects listed.